Introduction
Polyarteritis nodosa (PAN) is a rare form of vasculitis that causes inflammation and damage in medium-sized arteries. Because these blood vessels supply organs such as the nerves, kidneys, skin, intestines, and muscles, the resulting disease pattern can be widespread and varied. Diagnosis is not based on a single symptom or laboratory value. Instead, medical professionals combine clinical findings, blood tests, imaging studies, and sometimes tissue biopsy to identify the characteristic pattern of arterial inflammation and injury.
Accurate diagnosis matters because PAN can progress rapidly and lead to organ ischemia, aneurysm formation, nerve damage, kidney problems, intestinal complications, or severe systemic illness. It also needs to be distinguished from other vasculitides, infections, autoimmune diseases, and vascular disorders that may require different treatment. In addition, PAN is biologically distinct from small-vessel vasculitis because it primarily affects medium arteries and classically does not cause glomerulonephritis or significant pulmonary capillaritis. Recognizing that pattern helps clinicians focus the workup appropriately.
Recognizing Possible Signs of the Condition
Suspicion of PAN usually begins when a patient presents with a combination of constitutional symptoms and signs of organ injury that do not fit a single common diagnosis. Fever, fatigue, weight loss, muscle aches, and general malaise are frequent early clues. These systemic symptoms reflect inflammatory activity within vessel walls and reduced blood flow to tissues.
Because the disease affects arteries that feed multiple organs, the presentation can vary. Some patients develop painful skin nodules, livedo reticularis, ulcers, or areas of skin discoloration caused by impaired circulation. Others have peripheral neuropathy, often in the form of mononeuritis multiplex, which can cause sudden numbness, weakness, or foot drop when blood supply to individual nerves is compromised. Abdominal pain after meals, nausea, bowel ischemia, or gastrointestinal bleeding may point to involvement of mesenteric arteries. Kidney involvement often causes high blood pressure or declining renal function rather than the heavy protein loss typical of glomerular diseases.
Doctors also become concerned when symptoms appear in a pattern suggestive of vascular inflammation rather than infection or a localized structural problem. Multiple organ systems affected at the same time, unexplained elevated inflammatory markers, or findings of ischemia in different territories can prompt a targeted vasculitis evaluation.
Medical History and Physical Examination
The diagnostic process starts with a detailed history. Clinicians ask when symptoms began, how quickly they developed, and which organs seem affected. A sudden onset of nerve deficits, skin lesions, abdominal pain, or hypertension can be important because PAN often causes damage through segmental arterial inflammation and narrowing, producing ischemic symptoms in discrete areas. The timing and distribution of symptoms help distinguish PAN from chronic degenerative disease or isolated organ disorders.
Medical history also focuses on conditions associated with vasculitis-like syndromes or with secondary forms of PAN. A key question is exposure to hepatitis B, since hepatitis B infection can trigger a PAN-like immune complex vasculitis. Clinicians may also review prior infections, autoimmune disease, medication exposures, substance use, and family history. Although classic PAN is not an inherited disease, these details can shift the diagnostic pathway and help identify alternative causes.
During physical examination, healthcare professionals look for signs of vascular injury in multiple organs. They may check blood pressure carefully, since renovascular involvement can cause hypertension. Skin examination can reveal nodules, purpura, livedo reticularis, ulcers, or digital ischemia. A neurologic exam may detect asymmetric weakness, sensory loss, or reduced reflexes that suggest multifocal nerve injury. Abdominal tenderness, diminished pulses, or signs of testicular pain may also support the possibility of systemic vasculitis. The exam is not diagnostic by itself, but it guides which tests are most likely to provide useful evidence.
Diagnostic Tests Used for Polyarteritis nodosa
There is no single screening test that definitively proves PAN in every case. Diagnosis usually depends on a combination of laboratory studies, imaging, and tissue confirmation when feasible. The overall goal is to document medium-vessel inflammation and to assess the degree of organ injury.
Laboratory tests are usually obtained first. These often include complete blood count, kidney function tests, liver enzymes, urinalysis, erythrocyte sedimentation rate, and C-reactive protein. Findings may show anemia of inflammation, elevated inflammatory markers, or kidney impairment. Urinalysis in PAN may be relatively bland compared with glomerulonephritis, because the disease primarily affects arteries rather than the glomerular capillaries. Clinicians also test for hepatitis B and sometimes hepatitis C and HIV, since infectious triggers or mimics can change the diagnosis and treatment plan. Autoimmune serologies such as antinuclear antibody, anti-neutrophil cytoplasmic antibodies (ANCA), complement levels, and rheumatoid factor may be ordered to help distinguish PAN from other systemic vasculitides. Importantly, classic PAN is typically ANCA-negative, which is one clue rather than a standalone criterion.
Imaging tests are central when organ involvement suggests medium-artery disease. Angiography, including computed tomography angiography or magnetic resonance angiography, can reveal stenoses, occlusions, microaneurysms, irregular narrowing, or areas of vessel beading in renal, mesenteric, hepatic, or other medium-sized arteries. These findings reflect segmental inflammation and destruction of the arterial wall. Conventional catheter angiography has historically been the most detailed method and remains valuable when a high-resolution vascular map is needed. Imaging can also assess complications such as bowel ischemia or renal artery involvement. Ultrasound may be used in selected settings, but it is generally less informative for deep medium-sized arteries than CT, MR, or catheter angiography.
Functional tests help define the extent of organ damage. Nerve conduction studies and electromyography can document a multifocal axonal neuropathy consistent with ischemic nerve injury. Renal function tests show whether kidney perfusion or function has been affected. In some patients, cardiac testing or gastrointestinal evaluation is required if symptoms point to those organs. These studies do not diagnose PAN directly, but they support the presence of ischemic injury in a pattern that fits medium-vessel vasculitis.
Tissue examination can provide the most direct confirmation when an accessible affected site is available. Biopsy specimens from skin, nerve, muscle, or other involved tissue may show transmural inflammation of a medium-sized artery with fibrinoid necrosis, arterial wall destruction, and mixed inflammatory infiltrates. Because PAN is segmental, a biopsy can miss diseased vessels if the sample is taken from uninvolved tissue. For that reason, doctors often choose a site with active clinical findings and may combine muscle and nerve biopsy when neuropathy is present. A skin biopsy of a recent lesion or an excisional biopsy of a symptomatic nodule may sometimes be informative. Biopsy is especially helpful when imaging is not definitive or when another diagnosis remains possible.
Interpreting Diagnostic Results
Doctors interpret PAN studies by looking for convergence between symptoms, exam findings, and objective evidence of medium-artery disease. A typical pattern might include systemic inflammation, negative ANCA testing, evidence of organ ischemia, and angiographic abnormalities such as microaneurysms or segmental stenoses in the renal or mesenteric circulation. When biopsy confirms necrotizing arteritis in a medium-sized artery, the diagnosis becomes much stronger.
Interpretation requires attention to what is not present as well as what is present. Significant glomerulonephritis, pulmonary capillaritis, or prominent small-vessel purpura may suggest a different vasculitis rather than classic PAN. Likewise, isolated elevated inflammatory markers without compatible organ findings are not enough to establish the diagnosis. Because the disease can be patchy, a negative biopsy or non-diagnostic angiogram does not automatically rule it out if the overall clinical picture remains convincing. In practice, physicians weigh the probability of PAN against alternative explanations and may repeat testing or obtain a different biopsy site when needed.
Conditions That May Need to Be Distinguished
Several disorders can resemble PAN at the time of presentation. ANCA-associated vasculitides, such as microscopic polyangiitis or granulomatosis with polyangiitis, can produce systemic inflammation, neuropathy, kidney disease, and skin lesions, but they usually involve small vessels and often cause glomerulonephritis or pulmonary disease. Distinguishing these disorders is important because serologies, imaging patterns, and biopsy findings may differ.
Infection-related vasculitis and septic embolic disease may also mimic PAN, especially when fever, elevated inflammatory markers, and multi-organ symptoms are present. Hepatitis B-associated vasculitis must be considered because it can produce a PAN-like syndrome. Atherosclerotic disease can create arterial narrowing or ischemic symptoms, but it does not cause the inflammatory vessel-wall destruction seen in PAN. Cholesterol embolization, thromboembolic disease, systemic lupus erythematosus, cryoglobulinemic vasculitis, and certain inherited or drug-related vascular disorders may also enter the differential diagnosis depending on the clinical setting. The distinction usually depends on combining serologic testing, infection evaluation, vascular imaging, and tissue pathology.
Factors That Influence Diagnosis
The diagnostic process can be influenced by the severity and location of disease. Patients with obvious skin lesions or accessible neuropathy may be easier to evaluate than those whose disease is confined to deep visceral arteries. In the latter case, angiography may carry more diagnostic weight than biopsy. Age also matters. PAN can occur in adults and, less commonly, children, and the clinical context may differ. Pediatric cases are sometimes linked to systemic inflammatory syndromes or post-infectious triggers, which changes the workup.
Related medical conditions influence both suspicion and interpretation. Hepatitis B infection, for example, can point toward a secondary form of PAN and may alter serologic and treatment decisions. Kidney disease, diabetes, hypertension, or peripheral vascular disease can make it harder to distinguish vasculitic ischemia from more common chronic disorders. Prior immunosuppressive therapy can blunt inflammatory markers or alter biopsy yield. The timing of testing also matters, since biopsy is more likely to be informative when performed on active, untreated lesions.
Conclusion
Polyarteritis nodosa is diagnosed by recognizing a pattern of medium-artery inflammation and ischemic organ injury, then confirming that pattern with targeted testing. Clinicians begin with symptoms, medical history, and physical examination, looking for signs that point to multi-organ vascular disease. Laboratory studies help identify inflammation, assess organ function, and exclude mimicking conditions. Imaging, especially angiography, can reveal the characteristic arterial abnormalities of PAN. When possible, tissue biopsy provides direct evidence of necrotizing arteritis. The diagnosis is therefore a synthesis of clinical reasoning and objective findings rather than a single test result.
Because PAN can be serious and can resemble other vasculitides or infectious and vascular disorders, careful interpretation is essential. The most reliable diagnosis comes from combining the distribution of symptoms, the pattern of laboratory abnormalities, the vascular imaging findings, and histologic confirmation when available. This layered approach allows medical professionals to identify PAN accurately and distinguish it from other causes of systemic illness.